SEC Form 4 research
| Issuer | RenovoRx, Inc. |
|---|---|
| Tickers | RNXT |
| Reporting owners | 17 |
| Officers and directors | 8 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-01 | Macfarlane K. Angela | A | 55,924 | $0 | Not reported |
| 2026-10-02 | 2026-10-01 | Spiegel Robert J. | A | 55,924 | $0 | Not reported |
| 2026-10-02 | 2026-10-01 | RYAN UNA S | A | 55,924 | $0 | Not reported |
| 2026-10-02 | 2026-10-01 | Marton Laurence | A | 55,924 | $0 | Not reported |
| 2026-09-15 | 2026-09-10 | VOLL MARK | A | 80,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.